Literature DB >> 33064962

Dynamics of Atrial Fibrillation Mechanisms and Comorbidities.

Jordi Heijman1, Dominik Linz1,2,3,4, Ulrich Schotten1,5.   

Abstract

Atrial fibrillation (AF) contributes to morbidity and mortality of millions of individuals. Its molecular, cellular, neurohumoral, and hemodynamic pathophysiological mechanisms are complex, and there is increasing awareness that a wide range of comorbidities can contribute to AF-promoting atrial remodeling. Moreover, recent research has highlighted that AF risk is not constant and that the temporal variation in concomitant conditions contributes to the complexity of AF dynamics. In this review, we provide an overview of fundamental AF mechanisms related to established and emerging comorbidities or risk factors and their role in the AF-promoting effects. We focus on the accumulating evidence for the relevance of temporally dynamic changes in these risk factors and the consequence for AF initiation and maintenance. Finally, we highlight the important implications for future research and clinical practice resulting from the dynamic interaction between AF risk factors and mechanisms.

Entities:  

Keywords:  atrial fibrillation; comorbidities; dynamics; mechanisms; risk factors

Year:  2020        PMID: 33064962     DOI: 10.1146/annurev-physiol-031720-085307

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  9 in total

Review 1.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

2.  Association of RDW, NLR, and PLR with Atrial Fibrillation in Critical Care Patients: A Retrospective Study Based on Propensity Score Matching.

Authors:  Yao-Zong Guan; Rui-Xing Yin; Peng-Fei Zheng; Chun-Xiao Liu; Bi-Liu Wei; Guo-Xiong Deng
Journal:  Dis Markers       Date:  2022-05-27       Impact factor: 3.464

Review 3.  Atrial remodeling and atrial fibrillation recurrence after catheter ablation : Past, present, and future developments.

Authors:  Sotirios Nedios; Frank Lindemann; Jordi Heijman; Harry J G M Crijns; Andreas Bollmann; Gerhard Hindricks
Journal:  Herz       Date:  2021-07-05       Impact factor: 1.443

4.  CVAR-Seg: An Automated Signal Segmentation Pipeline for Conduction Velocity and Amplitude Restitution.

Authors:  Mark Nothstein; Armin Luik; Amir Jadidi; Jorge Sánchez; Laura A Unger; Eike M Wülfers; Olaf Dössel; Gunnar Seemann; Claus Schmitt; Axel Loewe
Journal:  Front Physiol       Date:  2021-05-24       Impact factor: 4.566

Review 5.  Emerging Antiarrhythmic Drugs for Atrial Fibrillation.

Authors:  Arnela Saljic; Jordi Heijman; Dobromir Dobrev
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

6.  Enhanced Cardiac CaMKII Oxidation and CaMKII-Dependent SR Ca Leak in Patients with Sleep-Disordered Breathing.

Authors:  Michael Arzt; Marzena A Drzymalski; Sarah Ripfel; Sebastian Meindl; Alexander Biedermann; Melanie Durczok; Karoline Keller; Julian Mustroph; Sylvia Katz; Maria Tafelmeier; Simon Lebek; Bernhard Flörchinger; Daniele Camboni; Sigrid Wittmann; Johannes Backs; Christof Schmid; Lars S Maier; Stefan Wagner
Journal:  Antioxidants (Basel)       Date:  2022-02-08

7.  Self-Reported Mobile Health-Based Risk Factor and CHA2DS2-VASc-Score Assessment in Patients With Atrial Fibrillation: TeleCheck-AF Results.

Authors:  Astrid N L Hermans; Monika Gawałko; Henrike A K Hillmann; Afzal Sohaib; Rachel M J van der Velden; Konstanze Betz; Dominique Verhaert; Daniel Scherr; Julia Meier; Arian Sultan; Daniel Steven; Elena Terentieva; Ron Pisters; Martin Hemels; Leonard Voorhout; Piotr Lodziński; Bartosz Krzowski; Dhiraj Gupta; Nikola Kozhuharov; Henri Gruwez; Kevin Vernooy; Nikki A H A Pluymaekers; Jeroen M Hendriks; Martin Manninger; David Duncker; Dominik Linz
Journal:  Front Cardiovasc Med       Date:  2022-01-19

8.  Prognostic Impact and Predictors of New-Onset Atrial Fibrillation in Heart Failure.

Authors:  Hyo-In Choi; Sang Eun Lee; Min-Seok Kim; Hae-Young Lee; Hyun-Jai Cho; Jin Oh Choi; Eun-Seok Jeon; Kyung-Kuk Hwang; Shung Chull Chae; Sang Hong Baek; Seok-Min Kang; Dong-Ju Choi; Byung-Su Yoo; Kye Hun Kim; Myeong-Chan Cho; Byung-Hee Oh; Jae-Joong Kim
Journal:  Life (Basel)       Date:  2022-04-13

9.  In-silico drug trials for precision medicine in atrial fibrillation: From ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria.

Authors:  Albert Dasí; Aditi Roy; Rafael Sachetto; Julia Camps; Alfonso Bueno-Orovio; Blanca Rodriguez
Journal:  Front Physiol       Date:  2022-09-15       Impact factor: 4.755

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.